RMD Income Statement

Resmed Inc - Revenue, Expenses & Profit Analysis

Stock Price

$256.26

Market Cap

$37.41B

P/E Ratio

25.3

EPS (TTM)

$10.12

Most Recent Quarter

Period: 2025-06-30(2025-06-30)

Revenue

Total sales from operations

$5.15B

+9.8% YoY

Cost of Revenue

Direct costs of sales

$2.09B

Gross Profit

Revenue - Cost of Revenue

$3.05B

Margin: 61.5%

Operating Income

Gross Profit - Operating Expenses

$1.69B

Margin: 0.4%

Interest Expense

Cost of debt

$12.61M

Net Income

Bottom line profit

$1.40B

Margin: 0.3%

Profitability Metrics

Gross Margin

61.5%

Operating Margin

0.4%

Net Margin

0.3%

Return on Equity

0.3%

Historical Income Statements

PeriodRevenueGross ProfitOperating IncomeNet IncomeEPS
2025-06-30$5.15B$3.05B$1.69B$1.40B$-
2024-06-30$4.69B$2.66B$1.32B$1.02B$-
2023-06-30$4.22B$2.36B$1.13B$897.56M$-
2022-06-30$3.58B$2.02B$1.00B$779.44M$-
2021-06-30$3.20B$1.84B$903.68M$474.50M$-

View Complete Financial Analysis

Full income statements, balance sheets, cash flows, and AI-powered insights

Open Full Analysis

Frequently Asked Questions

What is RMD's revenue?

RMD's most recent quarterly revenue was $5.15B, representing a growth of 9.8% year-over-year.

Is RMD profitable?

RMD reported a profit of $1.40B in the most recent quarter. The net profit margin is 0.3%.

What is RMD's operating income?

RMD's operating income was $1.69B in the most recent quarter. The operating margin is 0.4%.

What is RMD's earnings per share (EPS)?

EPS data is available in the income statement.

What is RMD's gross profit margin?

RMD has a gross profit margin of 61.5%, indicating the profitability of core operations before operating expenses.

Explore Categories